From: Role of MRI in diagnosis of prostate cancer and correlation of results with transrectal ultrasound guided biopsy “TRUS”
MRI
Biopsy
Total
Malignant
Benign
Positive/ non-specific
21 (70.0%) TP
7 (23.4%) FP
28 (93.3%)
Negative
1 (3.3%) FN
1 (3.3%) TN
2 (6.7%)
22 (73.3%)
8 (26.7%)
30 (100.0%)
Kappa (95% CI)
0.104 (0.000–0.421)
P
0.440